Wockhardt Ltd 2022 AR2
The report highlights Wockhardt Limited's performance and strategic initiatives for the fiscal year 2021-2022, emphasizing its resilience and focus on innovation, intellectual property, and healthcare infrastructure. Key achievements include the successful subscription of a Rights Issue aggregating ’748 crore to reduce debt and fund R&D, and a collaboration with Serum Life Sciences UK to deliver a global vaccine programme of 150 million doses annually. The company also advanced its New Chemical Entity (NCE) antibiotic program, with six NCEs holding QIDP status from the US FDA, and partnered with Jiangxi Jemincare for the development of Nafithromycin in China. Additionally, Wockhardt Foundation's CSR initiatives, including the Mobile 1000 programme, touched over 3 million lives during the year.
Company: Wockhardt Ltd
Sector: Manufacturing
Country: India
Year: 2022
Type: AR2
Pages: 235
Back to company
Wockhardt Ltd
Annual Report
The report highlights Wockhardt Limited's performance and strategic initiatives for the fiscal year 2021-2022, emphasizing its resilience and focus on innovation, intellectual property, and healthcare infrastructure. Key achievements include the successful subscription of a Rights Issue aggregating ’748 crore to reduce debt and fund R&D, and a collaboration with Serum Life Sciences UK to deliver a global vaccine programme of 150 million doses annually. The company also advanced its New Chemical Entity (NCE) antibiotic program, with six NCEs holding QIDP status from the US FDA, and partnered with Jiangxi Jemincare for the development of Nafithromycin in China. Additionally, Wockhardt Foundation's CSR initiatives, including the Mobile 1000 programme, touched over 3 million lives during the year.
Sign in for free to access detailed sustainability data, reporting standards, and ESG metrics.
Document Details
Report Year
2022
Reporting Period
Apr 1, 2021 - Mar 31, 2022
Fiscal Year
2022
Type
Annual Report with Sustainability Disclosures
Language
English
Pages
File Size
Standards & Assurance
Assurance
Assurance Provider
Assurance Standard
ESG Data?Experimental: AI-extracted data, may contain inaccuracies
Women on Board
Employees